MAPK8 and metabolic dysfunction-associated steatohepatitis: Silybin has the capacity to transfer the phosphate group from JNK to Insulin receptor substrate 1 (IRS1), and the subsequently, IRS1 bearing phosphate group can counteract insulin resistance to ameliorate NASH [40].